Perimenopause Power Hour: Real Talk, Real Options, Real Relief

This is your Women's Health Podcast podcast. Welcome to the Women’s Health Podcast. Today we’re going straight into perimenopause—the years leading up to menopause when hormones begin to fluctuate and symptoms can feel confusing, disruptive, and often dismissed. According to the North American Menopause Society, perimenopause commonly starts in the late 30s to mid‑40s and can last several years, with hallmark changes in cycle length, hot flashes and night sweats, sleep disturbance, mood shifts, brain fog, and vaginal or sexual changes. The World Health Organization and major clinical bodies emphasize this is a natural transition, not a disease, but one that deserves informed care and real options. Here’s our plan: a fast primer, an expert conversation outline you can take to your own clinician, and empowering key takeaways you can act on today. Perimenopause 101, quickly. Estrogen and progesterone become erratic, especially in the late luteal phase, which can amplify premenstrual symptoms, anxiety, and sleep disruption. Irregular periods are common; heavy bleeding can occur and should be evaluated to rule out anemia, fibroids, or thyroid issues. The British Menopause Society and the American College of Obstetricians and Gynecologists both note that evidence‑based options include lifestyle strategies, targeted nonhormonal therapies, and menopausal hormone therapy when appropriate. An empowerment approach highlighted in the Lancet and summarized by UC San Diego Health encourages women to be equal partners in decisions, weighing benefits, risks, and personal values rather than being told to simply “tough it out.” Now, the interview. Imagine we’re joined by Dr. Elina Zeldina of Premier OBGYN of Ridgewood and a menopause specialist like Dr. Haleema Sheikh from the Marion Gluck Clinic. Dr. Zeldina, how do you clinically distinguish perimenopause from other causes of irregular cycles, and when do you order tests like thyroid function or iron studies versus diagnosing based on symptoms and age? What’s your framework for heavy bleeding in perimenopause—when do you recommend tranexamic acid, a levonorgestrel IUD, or referral for ultrasound? Sleep is foundational. What does the evidence say about sleep hygiene, cognitive behavioral therapy for insomnia, magnesium glycinate, melatonin timing, and when night sweats point to vasomotor treatment? For mood and brain fog, how do you choose between SSRIs or SNRIs such as escitalopram or venlafaxine, cognitive behavioral therapy, and lifestyle interventions like resistance training and alcohol reduction? On vasomotor symptoms, when do you reach for menopausal hormone therapy, what are your go‑to regimens for someone with a uterus versus without, and how do you counsel on the well‑studied benefits and risks, including breast cancer, clotting, and cardiovascular timing? For patients avoiding hormones, how effective are options like the neurokinin‑3 receptor antagonist fezolinetant, low‑dose paroxetine, or g This content was created in partnership and with the help of Artificial Intelligence AI.